898550-56-6

Basic information

• Product Name: 4,4',6'-tri(benzyloxy)-2'-hydroxy-3'-C-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)chalcone
• Synonyms: 4,4',6'-tri(benzyloxy)-2'-hydroxy-3'-C-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)chalcone
• CAS NO: 898550-56-6
• Molecular Weight: 1065.27
• Mol File: 898550-56-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4,4',6'-tri(benzyloxy)-2'-hydroxy-3'-C-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)chalcone(CAS DataBase Reference)
• NIST Chemistry Reference: 4,4',6'-tri(benzyloxy)-2'-hydroxy-3'-C-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)chalcone(898550-56-6)
• EPA Substance Registry System: 4,4',6'-tri(benzyloxy)-2'-hydroxy-3'-C-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)chalcone(898550-56-6)

Safety Data

• Hazardous Substances Data: 898550-56-6(Hazardous Substances Data)

Upstream product

• 84799-77-9 methyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside 
• 97-30-3 methyl D-glucopyranoside 
• 100-39-0 benzyl bromide 
• 480-66-0 2,4,6-trihydroxyacetophenone 
• 1309438-45-6 4,6-bis-hydroxy-3-C-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-2-hydroxyacetophenone 
• 18065-05-9 1-[2,4-bis(benzyloxy)-6-hydroxyphenyl]ethanone 
• 80300-30-7 1-O-acetyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose 
• 4291-69-4 2,3,4,6-Tetra-O-benzyl-D-glucopyranose 
• 4397-53-9 p-benzyloxybenzaldehyde 
• 169566-46-5 1-(4,6-bis(benzyloxy)-2-hydroxy-3-((2S,3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)ethanone 
• 89025-46-7 2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl fluoride 

Downstream Products

• 66026-80-0 4′,7-dihydroxy-8β-D-glucose isoflavone 
• 898550-57-7 (2E)-1-[2-acetoxy-4,6-dibenzyloxy-3-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)]phenyl-3-(4-benzyloxyphenyl)prop-2-en-1-one 

Relevant articles and documents

Exploiting the therapeutic potential of 8-β- d -glucopyranosylgenistein: Synthesis, antidiabetic activity, and molecular interaction with islet amyloid polypeptide and amyloid β-peptide (1-42)

8-β-d-Glucopyranosylgenistein (1), the major component of Genista tenera, was synthesized and showed an extensive therapeutical impact in the treatment of STZ-induced diabetic rats, producing normalization of fasting hyperglycemia and amelioration of exce

Practical synthesis of a C-glycosyl flavonoid via O→C glycoside rearrangement

The C-glycosylation of 2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl fluoride and 2-acetylphloroglucinol 3,5-bis(alkyl ether) in the presence of boron trifluoride etherate as an activator stereoselectively gave the β-C-glucoside in a good yield via O→C glycos